Press Releases

April 3, 2006

Takeda Pharmaceutical Company Limited

Osaka, Japan, --- Takeda Pharmaceutical Company Limited ("Takeda", President & COO : Yasuchika Hasegawa) announced today that all of Takeda's shares of Mitsui Takeda Chemicals Inc. ("MTCI", President: Masafumi Kataita) had been transferred to Mitsui Chemicals, Inc. ("MCI", President: Kenji Fujiyoshi) on April 1. Upon transfer of shares, MTCI changed its name to Mitsui Chemicals Polyurethanes, Inc.

MTCI was established as a joint venture between MCI (51%) and Takeda (49%) in April 2001, and it is stipulated in the original agreement that the transfer of shares held by Takeda to MCI will take place after five years from the start of MTCI's commercial operation.

Since start of the operation in 2001, MTCI has been steadily expanding its business as one of the leading companies of urethane and urethane derivatives business in Asian market.

"Our former urethane and urethane derivatives business transferred to MTCI has been successfully achieving growth till now,"said Yasuchika Hasegawa, President & COO of Takeda. "We believe that the company will maintain and further strengthen the leading position in the business of urethane raw materials and urethane resins, which is one of  core businesses of MCI group."

# # #